Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells (Q44237000)

1 December 2017

title

Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells (English)

1 reference

respiratory syncytial virus

1 December 2017

main subject

0 references

RSV major surface glycoprotein G

0 references

modulation by virus of host process

0 references

author name string

Ralf Arnold

1

1 reference

1 December 2017

Brigitte König

2

1 reference

1 December 2017

Hermann Werchau

3

1 reference

1 December 2017

Wolfgang König

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

1 December 2017

number of pages

14

1 reference

inferred from page(s)

published in

Virology

1 reference

1 December 2017

volume

330

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

384-397

1 reference

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Molecular epidemiology of respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

RANTES may be predictive of later recurrent wheezing after respiratory syncytial virus bronchiolitis in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Post-translational Processing and Oligomerization of the Fusion Glycoprotein of Human Respiratory Syncytial Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Gene expression in epithelial cells in response to pneumovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Respiratory syncytial virus infection in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Respiratory syncytial virus G-protein modulates cytokine release from human peripheral blood mononuclear cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Immunity and immunopathology to respiratory syncytial virus. The mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Autocrine regulation of interleukin-8 by interleukin-1alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Development of a sensitive multi-well colorimetric assay for active NFkappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Enhanced virulence, airway inflammation and impaired lung function induced by respiratory syncytial virus deficient in secreted G protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

NF-kappaB: a key role in inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

RANTES, macrophage-inhibitory protein 1alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

The interaction of neutrophils with respiratory epithelial cells in viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

ICAM-1 expression and low-molecular-weight G-protein activation of human bronchial epithelial cells (A549) infected with RSV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

7 January 2021

Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

7 January 2021

Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

7 January 2021

Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

7 January 2021

Epstein-Barr virus enters B cells and epithelial cells by different routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

7 January 2021

Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

7 January 2021

The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.004

7 January 2021

10.1016/J.VIROL.2004.10.004

Identifiers

DOI

1 reference

1 December 2017

1 reference